Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Kröger, Nicolaus  [Clear All Filters]
2014
Stübig, T., Badbaran, A., Luetkens, T., Hildebrandt, Y., Atanackovic, D., Binder, T.M.C., Fehse, B., and Kröger, N. (2014). 5-azacytidine promotes an inhibitory T-cell phenotype and impairs immune mediated antileukemic activity.Mediators Inflamm2014, 418292.
Chalandon, Y., Passweg, J.R., Guglielmi, C., Iacobelli, S., Apperley, J., Schaap, N.P.M., Finke, J., Robin, M., Fedele, R., Bron, D., et al. (2014). Early administration of donor lymphocyte infusions upon molecular relapse after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia: a study by the Chronic Malignancies Working Party of the EBMT.Haematologica.
Triviai, I., Ziegler, M., Bergholz, U., Oler, A.J., Stübig, T., Prassolov, V., Fehse, B., Kozak, C.A., Kröger, N., and Stocking, C. (2014). Endogenous retrovirus induces leukemia in a xenograft mouse model for primary myelofibrosis.Proc Natl Acad Sci U S A.
Nitsch, E., Mina, S., Brammer, I., Pace, A., Schuch, G., Bokemeyer, C., Zander, A., Kröger, N., and Ayuk, F. (2014). Synergistic cytotoxic activity of treosulfan and gemcitabine in pancreatic cancer cell lines.Anticancer Res34, 1779-84.
Brissot, E., Labopin, M., Beckers, M.M., Socié, G., Rambaldi, A., Volin, L., Finke, J., Lenhoff, S., Kröger, N., Ossenkoppele, G.J., et al. (2014). Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia.Haematologica.
2016
Kröger, N., Solano, C., Wolschke, C., Bandini, G., Patriarca, F., Pini, M., Nagler, A., Selleri, C., Risitano, A., Messina, G., et al. (2016). Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease.N Engl J Med374, 43-53.
Kuba, K., Esser, P., Scherwath, A., Schirmer, L., Schulz-Kindermann, F., Dinkel, A., Balck, F., Koch, U., Kröger, N., Götze, H., et al. (2016). Cancer-and-treatment-specific distress and its impact on post-traumatic stress in patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT).Psychooncology.
Robin, M., Porcher, R., Wolschke, C., de Fontbrune, F.Sicre, Alchalby, H., Christopeit, M., Cassinat, B., Zabelina, T., de Latour, R.Peffault, Ayuk, F., et al. (2016). Outcome after transplantation according to reduced intensity conditioning regimen in patients transplanted for myelofibrosis.Biol Blood Marrow Transplant.
Schieferdecker, A., Shoshani, O., Westner, B., Zipori, D., Fehse, B., Kröger, N., and Ayuk, F. (2016). Potent in vitro and in vivo effects of polyclonal anti-human-myeloma globulins.Oncotarget.
Gratwohl, A., Iacobelli, S., Bootsman, N., van Biezen, A., Baldomero, H., Arcese, W., Arnold, R., Bron, D., Cordonnier, C., Ernst, P., et al. (2016). Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study.Ann Hematol.
Bruno, B., Auner, H.W., Gahrton, G., Garderet, L., Festuccia, M., Ladetto, M., Lemoli, R.M., Massaia, M., Morris, C., Palumbo, A., et al. (2016). Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting).Leuk Lymphoma1-13.
Ruggeri, A., Battipaglia, G., Labopin, M., Ehninger, G., Beelen, D., Tischer, J., Ganser, A., Schwerdtfeger, R., Glass, B., Finke, J., et al. (2016). Unrelated donor versus matched sibling donor in adults with acute myeloid leukemia in first relapse: an ALWP-EBMT study.J Hematol Oncol9, 89.

Pages